Sanitas AB has finished the project “Modernisation of Sanitas AB production”


In the new plant of Sanitas AB 191 workplaces were preserved, out of them 131
women workplaces, 85 workplaces of high qualification specialists. It is
anticipated to produce completely new form of injection preparations -
disposable syringes filled with medications. 

Capacities of the plant:
•	15 million of syringes per year with the possibility of expansion up to 35
million per year; 

•	 50 million ampoules per year;

•	15 million of vials of eye drops and/or nose drops per year;

•	300 million of tablets per year;

•	50 million of capsules per year. The new plant has the possibility to
manufacture small batches of medications. 

Total increase of production capacities, compared to the old Sanitas AB factory
- 3 times. During the project duration, the contract manufacture package for 3
different medication forms was prepared: 
•	disposable syringes filled with medications;
•	ampoules;
•	solid forms of medication.

Negotiations with 2 potential costumers for contractual manufacture services
were initiated.During the project duration, production of 19 medications was
terminated, and prepared for the production of 11 new medications.3 dossiers of
medications, being released from patented protection, were acquired and
registered. 

The total amount for the construction of the new plant were 68 mio LTL; the
support from EU funds were 16,06* mio LTL. 

* - asterisk marked 16,06 mio comprises 1,82 mio LTL, which shall be
transferred after LVPA confirms the final payment request. 
 		 

Jurist
Alina Nausedaite
+ 370 22 67 25
GlobeNewswire